Molecular classification of hepatoblastoma and prognostic value of the HB 16‐gene signature
Marie‐Annick Buendia, Carolina Armengol, Stefano Cairo – 16 May 2017
Reply
Yan Wang, Arun J. Sanyal – 16 May 2017
Expansion and intensification of humoral autoimmune response in the transition from preclinical to full‐blown primary biliary cholangitis
Alessandra Dellavance, Maria L.G. Ferraz, Eduardo L.R. Cançado, Luís E.C. Andrade – 16 May 2017
Immortal time bias or sorafenib effect in elderly patients with HCC?
Hanna K. Sanoff, YunKyung Chang, Jennifer L. Lund, Bert H. O'Neil, Stacie B. Dusetzina – 16 May 2017
Reply
Christophe Corpechot, Géraldine Dahlqvist, Olivier Chazouillères, Catherine Johanet – 16 May 2017
Regulatory T cell signatures in liver transplant recipients successfully weaned from immunosuppression: Getting from here to there
Matthew H. Levine, Tatiana Akimova, Douglas R. Murken, Wayne W. Hancock – 15 May 2017
Safety and efficacy of current direct‐acting antiviral regimens in kidney and liver transplant recipients with hepatitis C: Results from the HCV‐TARGET study
Varun Saxena, Vandana Khungar, Elizabeth C. Verna, Josh Levitsky, Robert S. Brown, Mohamed A. Hassan, Mark S. Sulkowski, Jacqueline G. O'Leary, Farrukh Koraishy, Joseph S. Galati, Alexander A. Kuo, Monika Vainorius, Lucy Akushevich, David R. Nelson, Michael W. Fried, Norah Terrault, K. Rajender Reddy – 15 May 2017 – Data outside of clinical trials with direct‐acting antiviral regimens with or without ribavirin as treatment of chronic hepatitis C virus in solid organ transplant recipients are limited.
The novel intracellular protein CREG inhibits hepatic steatosis, obesity, and insulin resistance
Quan‐Yu Zhang, Ling‐Ping Zhao, Xiao‐Xiang Tian, Cheng‐Hui Yan, Yang Li, Yan‐Xia Liu, Pi‐Xiao Wang, Xiao‐Jing Zhang, Ya‐Ling Han – 15 May 2017 – Cellular repressor of E1A‐stimulated genes (CREG), a novel cellular glycoprotein, has been identified as a suppressor of various cardiovascular diseases because of its capacity to reduce hyperplasia, maintain vascular homeostasis, and promote endothelial restoration. However, the effects and mechanism of CREG in metabolic disorder and hepatic steatosis remain unknown.